Vaccines Bioprocess Development and Commercialisation

Discover vaccine development, commercialisation and regulatory requirements.

USA 2015

University College London in collaboration with the Massachusetts Institute of Technology (MIT) is announcing its Vaccine Development course for 23rd-25th June 2015.

Vaccines represent a challenging area of development. There are many antigen designs and expression systems, all of which impact on the upstream and downstream process steps. This course seeks to use a combination of lectures and case studies to allow delegates to appreciate the different scale-up strategies within the complex regulatory framework for these multifarious biologics.

A team of outstanding international experts has agreed to join us in exploring the issues related to process development, regulation and commercialization of new vaccine products. The speakers will be available during for course for direct discussion and networking opportunities.

Speakers from MedImmune, MIT, Pfizer, Protein Sciences, GE Healthcare and GSK will focus on the key technical aspects critical for success and integrate those with an understanding of the regulatory environment.

The early draft programme is as follows.

DAY 1

  • Challenges and Progress Toward Developing a Malaria Vaccine (David Kaslow, PATH)
  • Process Development and Regulation of Recombinant Vaccines (Barry Buckland, BioLogicB)
  • Vaccine Delivery and Adjuvants (TBC)
  • Formulation  (TBC)
  • Downstream Processing (Charlie Cooney, MIT)
  • Evening Address - Katey Owen, Bill and Melinda Gates Foundation

DAY 2

  • Single Use technologies for Vaccine Porduction (GE Healthcare)
  • Scale Down Models for Vaccine Development (Tarit Mukhopadhyay UCL)
  • Vaccines: What and Where is the next frontier (Alain Pralong, GSK)
  • QbD in Vaccine Development (Sanofi, TBC)
  • Testing and Control of Adventitious Agents (CAACB, MIT)
  • Quality Control of Vaccines (Martin Wisher, Bioreliance)
  • Case Study 1 – Vaccine Project Management on LIAV Influenza vaccine (MedImmune)
  • Analytical Tools for Vaccine Characterization (Indresh Srivastava, Protein Sciences)

DAY 3

  • Viral Vaccines (John Aunins, Janis Biologics)
  • Medical Countermeasure Manufacturing (Robin Robinson, BARDA)
  • Polysaccharide and Conjugate Vaccine Development (Steve Kolodziej, Pfizer)
  • Case Study 2 -  Rapid Manufacturing (Christopher Love, MIT)
  • A networking dinner is included on the first night.

Meeting location

This meeting will be located at the MIT campus in Cambridge, MA (USA). The closest airport is Boston Logan Airport and is a short 30 minute drive to the meeting location. 

Course Price

The course is priced at £1,450. For more information or to book a place, please email mbi-training@ucl.ac.uk.

Past Events

  • London - 5th-7th December, 2012
  • India - 23rd-25th September, 2013
  • Portugal - 14th-16th April, 2014 at iBET

Upcoming Events

  • USA - 23rd-25th June, 2015 at MIT
Topics

Who should attend?

  • Specialised vaccines staff who would benefit from broadening their knowledge base
  • Those new to vaccine development (recent graduates / research scientists)
  • Project Managers, funders and policy-makers wanting to gain an understanding in vaccines.

Questions? E-mail mbi-training@ucl.ac.uk for further information.


Download the flyer for the course here.

Page last modified on 24 jul 14 12:48